Clinical trials now up for Exscientia's world first AI-made drug
pharmaphorum - 30-Jan-2020Partnering with Japan's DSP, a milestone is reached in OCD treatment
Join the club for FREE to access the whole archive and other member benefits.
R & D company based in Japan
Our Mission is "To contribute broadly to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide."
By channeling efforts into the research and development of new drugs, Sumitomo Pharma aims to realize this Mission and provide innovative and useful pharmaceuticals and healthcare solutions to people in Japan and around the world.
We are committed to contributing to the betterment of healthcare and fuller lives of people in three disease areas - Oncology, Psychiatry & Neurology (CNS), and Other areas (urological diseases, gynecological diseases, rare diseases, infectious diseases, etc.) - as well as in such modalities as small molecules and regenerative medicine/cell therapy.
Previously known as Sumitomo Dainippon Pharma Co., Ltd.
Visit website: https://www.sumitomo-pharma.com/
Details last updated 03-Apr-2026
Partnering with Japan's DSP, a milestone is reached in OCD treatment
Can speed up drug discovery process using artificial intelligence
Will produce cells derived from iPS cells for commercial applications. Existing iPSC production ...